As of June 17, 2025, Cannlabs Inc has a Discounted Cash Flow (DCF) derived fair value of $0.00 per share. With the current market price at $0.00, this represents a potential upside of -74693764.2%.
| Key Metrics | Value |
|---|---|
| DCF Fair Value (5-year) | $0.00 |
| DCF Fair Value (10-year) | $0.00 |
| Potential Upside (5-year) | -3406305.4% |
| Potential Upside (10-year) | -74693764.2% |
| Discount Rate (WACC) | 5.2% - 11.9% |
Revenue is projected to grow from $1 million in 12-2014 to $4897 million by 12-2024, representing a compound annual growth rate of approximately 133.9%.
| Fiscal Year | Revenue (USD millions) | Growth |
|---|---|---|
| 12-2014 | 1 | 354% |
| 12-2015 | 4 | 184% |
| 12-2016 | 11 | 181% |
| 12-2017 | 31 | 180% |
| 12-2018 | 74 | 143% |
| 12-2019 | 170 | 129% |
| 12-2020 | 372 | 119% |
| 12-2021 | 764 | 105% |
| 12-2022 | 1486 | 95% |
| 12-2023 | 2732 | 84% |
| 12-2024 | 4897 | 79% |
Net profit margin is expected to improve from -238% in 12-2014 to -161% by 12-2024, driven by operational efficiency and economies of scale.
| Fiscal Year | Net Profit (USD millions) | Profit Margin |
|---|---|---|
| 12-2014 | (3) | -238% |
| 12-2015 | (7) | -171% |
| 12-2016 | (18) | -169% |
| 12-2017 | (51) | -167% |
| 12-2018 | (122) | -165% |
| 12-2019 | (277) | -163% |
| 12-2020 | (603) | -162% |
| 12-2021 | (1,237) | -162% |
| 12-2022 | (2,402) | -162% |
| 12-2023 | (4,406) | -161% |
| 12-2024 | (7,881) | -161% |
with a 5-year average of $0 million. Projected CapEx is expected to maintain at approximately 10% of revenue.
Depreciation is based on an average useful life of 5 years for capital assets.
| Fiscal Year | D&A (USD millions) |
|---|---|
| 12-2015 | 0 |
| 12-2016 | 0 |
| 12-2017 | 1 |
| 12-2018 | 2 |
| 12-2019 | 6 |
| 12-2020 | 13 |
Net working capital is expected to increase gradually, with projected changes affecting free cash flow.
| Components | Average Days |
|---|---|
| Days Receivables | 13 |
| Days Inventory | 0 |
| Days Payables | 0 |
| Fiscal Year | EBITDA | Tax | CapEx | Change in NWC | FCF |
|---|---|---|---|---|---|
| 9M/2015 | (7) | (2) | 0 | (0) | (5) |
| 2016 | (24) | (7) | 1 | 0 | (19) |
| 2017 | (68) | (19) | 3 | 1 | (53) |
| 2018 | (162) | (45) | 7 | 2 | (126) |
| 2019 | (367) | (102) | 16 | 5 | (287) |
| Valuation Method | Fair Price (USD) | Potential Upside |
|---|---|---|
| 5-Year DCF (Growth) | 0.00 | -3406305.4% |
| 10-Year DCF (Growth) | 0.00 | -74693764.2% |
| 5-Year DCF (EBITDA) | 0.00 | NaN% |
| 10-Year DCF (EBITDA) | 0.00 | NaN% |
Is Cannlabs Inc (CANL) a buy or a sell? Cannlabs Inc is definitely a sell. Based on our DCF analysis, Cannlabs Inc (CANL) appears to be overvalued with upside potential of -74693764.2%. The company's strong projected growth in revenue and profitability, coupled with consistent capital expenditure, supports our positive outlook on its intrinsic value.
Key investment drivers include:
Investors should consider reducing exposure at the current market price of $0.00.